The CIMAvax-EGF vaccine against lung cancer, created by Cuban scientists at the Center for Molecular Immunology, goes through its last phase of clinical trial in the province of Cienfuegos.
Counting on an institution, such as the Institute of Nephrology, Dr Abelardo Buch López, of the Cuban capital, is a blessing for those searching the recovery of their renal health in this service, which on December First will turn five decades of its foundation, with delivery of love, hard to match.